Current understanding and management of CAR T cell-associated toxicities
JN Brudno, JN Kochenderfer - Nature Reviews Clinical Oncology, 2024 - nature.com
Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of several
haematological malignancies and is being investigated in patients with various solid …
haematological malignancies and is being investigated in patients with various solid …
Current understanding and management of CAR T cell-associated toxicities.
JN Brudno, JN Kochenderfer - Nature reviews. Clinical Oncology, 2024 - europepmc.org
Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of several
haematological malignancies and is being investigated in patients with various solid …
haematological malignancies and is being investigated in patients with various solid …
Current understanding and management of CAR T cell-associated toxicities
JN Brudno, JN Kochenderfer - Nature reviews. Clinical oncology - pubmed.ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of several
haematological malignancies and is being investigated in patients with various solid …
haematological malignancies and is being investigated in patients with various solid …